查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941462

美國外泌體市場規模、佔有率和趨勢分析報告：按產品/服務、應用、工作流程、最終用途和細分市場預測，2026-2033年

U.S. Exosomes Market Size, Share & Trends Analysis Report By Product & Service, By Application, By Workflow, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國外泌體市場概述

據估計，美國外泌體市場在 2025 年的價值為 1.156 億美元，預計到 2033 年將達到 7.168 億美元。

預計2026年至2033年，該市場將以25.75%的複合年成長率成長。外泌體應用領域的不斷拓展是推動市場成長的主要因素。外泌體分離技術和分析方法的進步也促進了市場成長，而癌症患者數量的增加則是推動市場成長的因素之一。

癌症發生率增加

癌症發生率上升是預測期內推動市場成長的主要因素之一，預計到 2025 年，僅在美國就將新增 200 萬例癌症病例。

外泌體作為潛在的生物標記物，在癌症早期檢測、疾病進展監測和療效評估方面備受關注。隨著全球癌症發病率的不斷上升，對先進診斷工具和標靶治療的需求日益成長，而基於外泌體的技術發展有望促進這些需求的實現。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數與趨勢

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析

第4章：美國外泌體市場按產品和服務分類的估算和趨勢分析

  • 美國外泌體產品與服務儀錶板
  • 依產品/服務分析美國外泌體的變化
  • 試劑盒和試劑
  • 裝置
  • 服務

第5章：美國外泌體市場按應用領域分類的趨勢分析

  • 美國外泌體市場按應用分類的概覽
  • 依應用分析美國外泌體市場波動情況
  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他

6. 美國外泌體市場依工作流程分類的估算與趨勢分析

  • 美國外泌體市場工作流程特定儀表板
  • 依工作流程分析美國外泌體市場差異
  • 分離方法
    • 超速離心
    • 基於微珠的免疫捕獲
    • 降水法
    • 過濾
    • 其他
  • 下游分析
    • 下游分析
    • 利用流式細胞技術進行細胞表面標誌物分析
    • 利用印跡法和ELISA法進行蛋白質分析
    • 利用NGS和PCR進行RNA分析
    • 利用質譜法進行蛋白質體分析
    • 其他

7. 美國外泌體市場依最終用途分類的估算與趨勢分析

  • 美國外泌體市場按最終用途分類的概覽
  • 以最終用途分析美國外泌體市場波動
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 學術和研究機構

第8章 競爭情勢

  • 參與企業
  • 2025年公司市場分析
  • 公司簡介
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Hologic Inc.
    • Bio-Techne
    • RoosterBio, Inc
    • Fujifilm Holdings Corporation
    • Lonza
    • Miltenyi Biotec
    • QIAGEN
    • CellBio Scientific
Product Code: GVR-4-68040-242-7

U.S. Exosomes Market Summary

The U.S. exosomes market size was estimated at USD 115.6 million in 2025 and is projected to reach USD 716.8 million by 2033, growing at a CAGR of 25.75% from 2026 to 2033. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contributing to market growth and are fueled by the increasing prevalence of cancer.

Increasing Prevalence of Cancer

The increasing prevalence of cancer is one of the key factors contributing to market growth over the forecast period. In 2025, an estimated over 2 million new cancer cases were diagnosed in the U.S. alone.

Exosomes have gained attention for their potential as biomarkers for early cancer detection, monitoring disease progression, and assessing therapeutic responses. With the global incidence of cancer on the rise, there is an increasing need for advanced diagnostic tools and targeted treatments, the development of which can be facilitated by exosome-based technologies.

U.S. Exosomes Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. exosomes market based on product & service, application, workflow, and end use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & reagents
  • Instruments
  • Services
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Isolation Methods
    • Ultracentrifugation
    • Immunocapture on beads
    • Precipitation
    • Filtration
    • Others
  • Downstream Analysis
    • Cell surface marker analysis using flow cytometry
    • Protein Analysis using blotting & ELISA
    • RNA analysis with NGS & PCR
    • Proteomic analysis using mass spectroscopy
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Application Segment
    • 1.1.2. Product & Service Segment
    • 1.1.3. Workflow Segment
    • 1.1.4. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
      • 3.2.1.2. Advanced applications of exosomes
      • 3.2.1.3. Growth in strategic initiatives for exosome-based therapies
      • 3.2.1.4. Increasing prevalence of cancer
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations pertaining to approval
      • 3.2.2.2. Challenges associated with the implementation of exosome-based therapies
      • 3.2.2.3. Reduction in funding for biomedical research
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Exosomes Market Product & Service Estimates & Trend Analysis

  • 4.1. U.S. Exosomes Product & Service Dashboard
  • 4.2. U.S. Exosomes Product & Service Movement Analysis
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Exosomes Market Application & Trend Analysis

  • 5.1. U.S. Exosomes Market Application Dashboard
  • 5.2. U.S. Exosomes Market Application Movement Analysis
  • 5.3. Cancer
    • 5.3.1. Cancer Market, 2021 - 2033 (USD Million)
  • 5.4. Neurodegenerative Diseases
    • 5.4.1. Neurodegenerative Diseases Market, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis

  • 6.1. U.S. Exosomes Market Workflow Dashboard
  • 6.2. U.S. Exosomes Market Workflow Movement Analysis
  • 6.3. Isolation Methods
    • 6.3.1. Isolation Methods Market, 2021 - 2033 (USD Million)
    • 6.3.2. Ultracentrifugation
      • 6.3.2.1. Ultracentrifugation Market, 2021 - 2033 (USD Million)
    • 6.3.3. Immunocapture On Beads
      • 6.3.3.1. Immunocapture On Beads Market, 2021 - 2033 (USD Million)
    • 6.3.4. Precipitation
      • 6.3.4.1. Precipitation Market, 2021 - 2033 (USD Million)
    • 6.3.5. Filtration
      • 6.3.5.1. Filtration Market, 2021 - 2033 (USD Million)
    • 6.3.6. Others
      • 6.3.6.1. Other Isolation Methods Market, 2021 - 2033 (USD Million)
  • 6.4. Downstream Analysis
    • 6.4.1. Downstream Analysis Market, 2021 - 2033 (USD Million)
    • 6.4.2. Cell Surface Marker Analysis Using Flow Cytometry
      • 6.4.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2021 - 2033 (USD Million)
    • 6.4.3. Protein Analysis Using Blotting & ELISA
      • 6.4.3.1. Protein Analysis Using Blotting & ELISA Market, 2021 - 2033 (USD Million)
    • 6.4.4. RNA Analysis With NGS & PCR
      • 6.4.4.1. RNA Analysis With NGS & PCR Market, 2021 - 2033 (USD Million)
    • 6.4.5. Proteomic Analysis Using Mass Spectrometry
      • 6.4.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2021 - 2033 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Other Downstream Analysis Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Exosomes Market End Use Estimates & Trend Analysis

  • 7.1. U.S. Exosomes Market End Use Dashboard
  • 7.2. U.S. Exosomes Market End Use Movement Analysis
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.4. Hospitals & Diagnostics Centers
    • 7.4.1. Hospitals & Diagnostics Centers Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2025
  • 8.3. Company Profiles
    • 8.3.1. Danaher
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Thermo Fisher Scientific, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Hologic Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Bio-Techne
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. RoosterBio, Inc
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Fujifilm Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Lonza
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Miltenyi Biotec
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CellBio Scientific
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. U.S. Exosomes Market, By Product, 2021 - 2033 (USD Million)
  • Table 3. U.S. Exosomes Market, By Application, 2021 - 2033 (USD Million)
  • Table 4. U.S. Exosomes Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 5. U.S. Exosomes Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 U.S. Exosomes Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 U.S. Exosomes Market: Product & service outlook and key takeaways
  • Fig. 13 U.S. Exosomes Market: Product & service movement analysis & market share 2025 & 2033
  • Fig. 14 Kits & reagents market, 2021 - 2033 (USD Million)
  • Fig. 15 Instruments market, 2021 - 2033 (USD Million)
  • Fig. 16 Services market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Exosomes Market: Application outlook and key takeaways
  • Fig. 18 U.S. Exosomes Market: Application movement analysis & market share
  • Fig. 19 Isolation methods market, 2021 - 2033 (USD Million)
  • Fig. 20 Ultracentrifugation market, 2021 - 2033 (USD Million)
  • Fig. 21 Immunocapture on beads market, 2021 - 2033 (USD Million)
  • Fig. 22 Precipitation market, 2021 - 2033 (USD Million)
  • Fig. 23 Filtration market, 2021 - 2033 (USD Million)
  • Fig. 24 Other isolation methods market, 2021 - 2033 (USD Million)
  • Fig. 25 Downstream analysis market, 2021 - 2033 (USD Million)
  • Fig. 26 Cell surface marker analysis using flow cytometry market, 2021 - 2033 (USD Million)
  • Fig. 27 Protein analysis using blotting & ELISA market, 2021 - 2033 (USD Million)
  • Fig. 28 RNA analysis with NGS & PCR market, 2021 - 2033 (USD Million)
  • Fig. 29 Proteomic analysis using mass spectroscopy market, 2021 - 2033 (USD Million)
  • Fig. 30 Other downstream analysis market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Exosomes Market: Application outlook and key takeaways
  • Fig. 32 U.S. Exosomes Market: Application movement analysis & market share
  • Fig. 33 Cancer market, 2021 - 2033 (USD Million)
  • Fig. 34 Neurodegenerative diseases market, 2021 - 2033 (USD Million)
  • Fig. 35 Cardiovascular diseases market, 2021 - 2033 (USD Million)
  • Fig. 36 Infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 37 Other applications market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Exosomes Market: End use outlook and key takeaways
  • Fig. 39 U.S. Exosomes Market: End use movement analysis & market share
  • Fig. 40 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 41 Hospitals & diagnostics centers market estimates and forecast, 2021 - 2033
  • Fig. 42 Academic and research institutes market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033